stockrow
Monday 9 November 2026
Export BON’s income statement to Excel — free account
Bon Natural Life Limited
BONBasic Materials Specialty Chemicals
Bon Natural Life Limited’s revenue for fiscal 2025 (year ended September 2025) was $18.7 million, down 21.7% from fiscal 2024.
1.11
0.01
−0.89%
Follow BON
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to September
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Mar ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | 16 | 16 | 18 | 25 | 30 | 30 | 24 | 19 | 58 | +1.9% | 2,742 | — | — | +14,588.2% | |
| Gross margin, % | — | — | 32.22 | 32.22 | 28.55 | 27.90 | 31.51 | 29.94 | 29.82 | 20.77 | 30.90 | (11.4) pt | ||||||
| EBT | — | — | 3 | (2) | 4 | 5 | 8 | 6 | 1 | (2) | 13 | n/m | ||||||
| EBT margin, % | — | — | 18.23 | 0.00 | 20.06 | 21.30 | 25.11 | 18.88 | 3.00 | (9.16) | 22.11 | (27.4) pt | ||||||
| Net income | — | 0 | 0 | 0 | 3 | 5 | 6 | 5 | 0 | (2) | (2) | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | 0.00 | 792.08 | 875.96 | 962.06 | 895.47 | 806.62 | 249.68 | 6.78 | 0.00 | n/m | |||||
| Earnings | — | — | — | 123.99 | 148.64 | 172.50 | 187.50 | 125.00 | 4.25 | (0.72) | 1.26 | n/m | ||||||
| Cash flow | — | — | 0.03 | 343.23 | 127.07 | 152.95 | (5.60) | (17.81) | (80.88) | 0.05 | 0.00 | +6.5% | ||||||
| Capex | — | — | 0.00 | (341.78) | (208.32) | (179.39) | (141.74) | (19.98) | (0.07) | (3.63) | 0.00 | n/m | ||||||
| Free cash flow | — | — | 0.03 | 1.44 | (81.25) | (26.45) | (147.34) | (37.79) | (80.95) | (3.58) | 0.00 | n/m | ||||||
| Book value | — | — | 0.00 | 350.88 | 529.95 | 1,001.31 | 900.97 | 983.11 | 464.39 | 21.05 | 0.00 | n/m | ||||||
| Shares, m | — | — | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | — | (14.6%) | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | 2,142.86 | 2,142.86 | 2,142.86 | 2,326.92 | 415.87 | 79.98 | 38.69 | 1.55 | 0.88 | 1,161.4 | |||||
| P/S | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| P/B | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/Sales | — | — | 0.09 | 0.09 | 0.09 | (0.02) | 0.03 | 0.02 | 0.01 | (0.07) | (0.12) | 0.0 | ||||||
| EV/FCF | — | — | 0.28 | 0.28 | 0.28 | 0.14 | (0.21) | (0.11) | (0.06) | 0.24 | 0.40 | 0.1 | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | 0 | 7 | 3 | 4 | 0 | (1) | (8) | 0 | (14) | (9.0%) | |||||
| Capex | — | — | (2) | (7) | (4) | (5) | (5) | (1) | 0 | (10) | (4) | +29.0% | ||||||
| Free cash flow | — | — | 0 | 0 | (2) | (1) | (5) | (1) | (8) | (10) | (18) | n/m | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | (2) | 6 | (1) | 9 | 8 | 15 | 23 | 19 | 23 | n/m | |||||
| Net debt | — | — | 1 | 3 | 4 | (1) | 2 | 1 | 1 | (4) | (7) | n/m | ||||||
| Shareholders’ equity | — | — | 7 | 7 | 11 | 27 | 30 | 36 | 44 | 58 | 51 | +34.6% | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | 13.16 | 23.90 | 19.54 | 14.90 | 16.93 | 10.97 | 0.74 | (2.71) | 0.00 | (15.9) pt | |||||
| ROIC | — | — | 27.61 | 0.00 | 14.77 | 13.20 | 12.81 | 9.98 | 2.59 | (1.89) | 0.00 | (29.5) pt | ||||||
| ROE | — | — | 108.67 | 0.00 | 33.10 | 24.45 | 22.03 | 13.91 | 0.99 | (3.90) | 0.00 | (112.6) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | 87 | 93 | 103 | 96 | 97 | 96 | — | +2.0% | |||||
| Revenue/emp, $m | — | — | 0.00 | 0.00 | 0.21 | 0.27 | 0.29 | 0.31 | 0.25 | 0.19 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Sep 2025 · latest quarter Jan 0001 · fundamentals updated 2 Nov 2026
Bon Natural Life Limited vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| FEAM 5E Advanced Materials, Inc. | $93.8M | — (loss-making) | — | — | n/m | +17.79% (above 0%: growing) | 0.00% | 0.00% | Compare |
| NTIC Northern Technologies International Corporation | $72.0M | — (loss-making) | 186× | +12.59% (above 0%: growing) | n/m | +327.52% (above 0%: growing) | 33.63% | 2.13% | Compare |
| CITR CitroTech Inc. | $58.7M | — (loss-making) | — (loss-making) | −59.18% (below 0%: shrinking) | n/m | −30.95% (below 0%: shrinking) | 3.21% | (1,244.78%) | Compare |
| LOOP Loop Industries, Inc. | $12.3M | — (loss-making) | — (loss-making) | −53.57% (below 0%: shrinking) | n/m | +52.28% (above 0%: growing) | 3.42% | (1,792.31%) | Compare |
| BON Bon Natural Life Limited | $9.1M | 0.9× | 4.5× | +20.95% (above 0%: growing) | −14.29% (below 0%: shrinking) | −260.38% (below 0%: shrinking) | 33.34% | 0.00% | |
| SNES Senestech, Inc. | $6.3M | — (loss-making) | — (loss-making) | +23.20% (above 0%: growing) | n/m | −42.77% (below 0%: shrinking) | 73.64% | (241.82%) | Compare |
| YMAT J-Star Holding Co., Ltd | $4.9M | — | — | — | — | — | — | — | Compare |
| CNEY CN Energy Group. Inc. | $3.9M | 2.9× | 1.1× | −99.90% (below 0%: shrinking) | +33.33% (above 0%: growing) | −113.57% (below 0%: shrinking) | 3.28% | 0.00% | Compare |
| BGLC BioNexus Gene Lab Corp. | $2.5M | — (loss-making) | — | −96.63% (below 0%: shrinking) | n/m | +44.32% (above 0%: growing) | 17.06% | (342.78%) | Compare |
| Median of peers | $9.3M | — | — | −56.37% | — | +17.79% | 3.42% | (241.82%) |